Skip to content

Talphera, Inc. TLPH Financing Cash Flow

Financing Cash Flow at other companies

Baxter International logo
Baxter InternationalBAX
-$11M+99.7%
AMP
Amphastar PharmaceuticalsAMPH
-$30.21M-108%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$7.92M+751%
Royalty Pharma logo
Royalty PharmaRPRX
-$272.67M+71.0%
PTH
Pelthos Therapeutics Inc.PTHS
$27.52M+10,909%
XOMA Corporation logo
XOMA CorporationXOMA
-$7.64M-10.8%

Other financials

Income statement

See full
Revenue--100%
Gross profit-$1.9M-52.7%
Operating income-$3.9M-35.4%
Net income-$2.6M+1.4%
EPS (diluted)-$0.10+37.5%

Balance sheet

See full
Cash & equivalents$3.8M-29.0%
Total debt$3.4M-79.7%
Total equity$18.5M+230%
Total assets$30.2M+101%

Cash flow

See full
Operating cash flow-$3.4M+2.0%
CapEx-
Free cash flow-$2.3M+42.9%

Valuation

See full
Market cap$53.46M+516%
P/S53,456.6×+53,135×

Profitability

See full
Gross margin-127.7%-136pp
Operating margin-1,451,600%-1,507,145pp
Net margin-1,425,300%-1,471,200pp
FCF margin-5,116.7%-6,779pp

Returns & leverage

See full
Return on equity-118.4%+15.4pp
Debt / equity0.2×
Current ratio5.3×+2.2×

Where this comes from

Reported directly by Talphera, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Talphera, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Talphera, Inc.'s financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Talphera, Inc.'s financing cash flow?
Talphera, Inc. (TLPH) reported financing cash flow of $4.04M in Q1 2026.
How has Talphera, Inc.'s financing cash flow changed year-over-year?
Talphera, Inc.'s financing cash flow increased by 80960.0% year-over-year, from -$5K to $4.04M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.